GlassScriptPhysician profile
Tyler David Calway
NPI 1861953879
$1,632.44
in general payments reported to CMS, 2019-2025
15 companies · $489 in 2025
The $489 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $717 · 2023: $219 · 2024: $208 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.11 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $610.87 | 2022 | |
| Pfizer INC. | $440.07 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $102.57 | 2022-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $79.40 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $71.75 | 2024-2025 | |
| Seqirus USA INC | $65.40 | 2025 | Flucelvax |
| Alk-Abello, INC | $44.91 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $43.89 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $40.52 | 2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $31.97 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $26.96 | 2025 | Neffy |
| Sobi, INC | $22.31 | 2023 | |
| Biomarin Pharmaceutical INC. | $18.19 | 2024 | Voxzogo 1.2mg |
| Kaleo, INC. | $17.86 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.77 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Calway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.